In patients with HIV, a diabetes drug may have benefits beyond lowering blood sugar. A new study from researchers at Washington University School of Medicine in St. Louis suggests the drug may prevent cardiovascular problems ...
May 14, 2015
0
88
The Food and Drug Administration outlined new, voluntary guidelines to lower sodium levels in food. But those with high blood pressure or who are at risk for heart disease may want to consider simply saying no to sodium.
Feb 21, 2022
0
46
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
May 7, 2020
0
1
Two doses of psilocybin, a compound found in psychedelic mushrooms, reduces heavy drinking by 83% on average among heavy drinkers when combined with psychotherapy, a new study shows. Led by researchers at NYU Grossman School ...
Aug 24, 2022
0
365
Half of all patients discharged from hospital after a heart attack are treated with beta-blockers unnecessarily. This is according to a new study published in the New England Journal of Medicine.
Apr 8, 2024
0
69
For many patients, cholesterol-lowering statin drugs can reduce the risk of strokes as well as heart attacks. But in a review article, Loyola University Health System neurologists caution that statins may not be appropriate ...
Aug 19, 2011
0
0
An alarming number of people nationwide are developing infections of either the heart's inner lining or valves, known as infective endocarditis, in large part, due to the current opioid epidemic. This new trend predominantly ...
Sep 18, 2019
0
11
Mediterranean and low fat dietary programs reduce the likelihood of death and heart attack in patients at heightened risk of cardiovascular disease, finds the first comparative review based on randomized trials of seven popular ...
Mar 29, 2023
0
37
Physical activity is potentially as effective as many drug interventions for patients with existing coronary heart disease and stroke, suggests a review of evidence published in BMJ today.
Oct 1, 2013
1
0
Up to 45% of patients with the most common inherited neuromuscular disease could benefit from a new "cocktail" drug being developed at the University of Alberta, according to research published this week in the Proceedings ...
Feb 23, 2022
1
161
